Literature DB >> 30779948

The relative toxicity of brodifacoum enantiomers.

Douglas L Feinstein1, Kamil Gierzal2, Asif Iqbal3, Sergey Kalinin4, Richard Ripper5, Matthew Lindeblad6, Alexander Zahkarov7, Alexander Lyubimov8, Richard van Breemen9, Guy Weinberg10, Israel Rubinstein11.   

Abstract

Brodifacoum (BDF) is a potent, long-acting anticoagulant rodenticide that can cause fatal poisoning in humans. The chemical structure of BDF includes 2 chiral carbons, resulting in 2 pairs of diastereomers, BDF-cis (R/S and S/R) and BDF-trans (R/R and S/S). However, the relative potency of these molecules is not known. The purpose of this study was to compare the in vitro and in vivo toxic effects of the 2 BDF diastereomer pairs. In adult Sprague-Dawley rats BDF-cis was significantly more toxic than BDF-trans (LD50 values of 219 versus 316 μg/kg, respectively) while racemic BDF had intermediate potency (266 μg/kg). In adult New Zealand white rabbits, BDF-cis had a longer half-life than BDF-trans which could contribute to its observed increased toxicity. Lastly, BDF-cis (10 μM), but not BDF-trans, damaged cultured SH-SY5Y human neuroblastoma cells by attenuating mitochondrial reductive capacity. Taken together, these data suggest that different toxic manifestations of BDF poisoning in mammals could be attributed, in part, to differences in relative enantiomer concentrations present in racemic formulations of this commercially-available toxicant. Published by Elsevier B.V.

Entities:  

Keywords:  Anticoagulation; Brodifacoum; Diastereomer; Enantiomer; Superwarfarins

Mesh:

Substances:

Year:  2019        PMID: 30779948      PMCID: PMC6408973          DOI: 10.1016/j.toxlet.2019.02.011

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  20 in total

1.  Novel 4-hydroxycoumarin anticoagulants active against resistant rats.

Authors:  M R Hadler; R S Shadbolt
Journal:  Nature       Date:  1975-01-24       Impact factor: 49.962

2.  The statistical sign test.

Authors:  W J DIXON; A M MOOD
Journal:  J Am Stat Assoc       Date:  1946-12       Impact factor: 5.033

3.  LC-MS-MS Analysis of Brodifacoum Isomers in Rat Tissue.

Authors:  Zane Z Hauck; Douglas L Feinstein; Richard B van Breemen
Journal:  J Anal Toxicol       Date:  2016-02-23       Impact factor: 3.367

4.  Synthesis and structure-activity relationships of novel warfarin derivatives.

Authors:  Markus Gebauer
Journal:  Bioorg Med Chem       Date:  2007-01-17       Impact factor: 3.641

5.  Structural perturbation of a dipalmitoylphosphatidylcholine (DPPC) bilayer by warfarin and its bolaamphiphilic analogue: A molecular dynamics study.

Authors:  Manuela Aseye Ayele Ayee; Charles William Roth; Belinda Sena Akpa
Journal:  J Colloid Interface Sci       Date:  2016-01-27       Impact factor: 8.128

Review 6.  Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle.

Authors:  Johannes Oldenburg; Carville G Bevans; Clemens R Müller; Matthias Watzka
Journal:  Antioxid Redox Signal       Date:  2006 Mar-Apr       Impact factor: 8.401

Review 7.  Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.

Authors:  Michael P Gulseth; Gloria R Grice; William E Dager
Journal:  Am J Health Syst Pharm       Date:  2009-01-15       Impact factor: 2.637

Review 8.  Long-Acting Anticoagulant Rodenticide (Superwarfarin) Poisoning: A Review of Its Historical Development, Epidemiology, and Clinical Management.

Authors:  Nathan King; Minh-Ha Tran
Journal:  Transfus Med Rev       Date:  2015-07-06

9.  Laboratory evaluation of WBA 8119 as a rodenticide for use against warfarin-resistant and non-resistant rats and mice.

Authors:  R Redfern; J E Gill; M R Hadler
Journal:  J Hyg (Lond)       Date:  1976-12

Review 10.  Pharmacogenetics of warfarin elimination and its clinical implications.

Authors:  H Takahashi; H Echizen
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

View more
  2 in total

1.  Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids.

Authors:  Douglas L Feinstein; Daniel G Nosal; Swetha Ramanathan; Jifang Zhou; Luying Chen; Ronald C Hershow; Richard B van Breemen; Erik Wright; John W Hafner; Israel Rubinstein
Journal:  Clin Toxicol (Phila)       Date:  2019-11-18       Impact factor: 4.467

2.  Chiral liquid chromatography-tandem mass spectrometry analysis of superwarfarin rodenticide stereoisomers - Bromadiolone, difenacoum and brodifacoum - In human plasma.

Authors:  Daniel G Nosal; Douglas L Feinstein; Richard B van Breemen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2021-01-07       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.